These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16191191)

  • 1. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A; Gerry S; Kaldis P; Solomon MJ
    BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.
    Cheng A; Xiong W; Ferrell JE; Solomon MJ
    Cell Cycle; 2005 Jan; 4(1):155-65. PubMed ID: 15611625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
    Gonzalez L; Nebreda AR
    Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
    Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
    J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK activation by non-cyclin proteins.
    Nebreda AR
    Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of cell-cycle progression by RINGO/Speedy E.
    Dinarina A; Ruiz EJ; O'Loghlen A; Mouron S; Perez L; Nebreda AR
    Biochem J; 2008 Mar; 410(3):535-42. PubMed ID: 18072937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new family of cyclin-dependent kinase activators.
    Dinarina A; Perez LH; Davila A; Schwab M; Hunt T; Nebreda AR
    Biochem J; 2005 Mar; 386(Pt 2):349-55. PubMed ID: 15574121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.
    Zheng F; Quiocho FA
    J Biol Chem; 2013 Oct; 288(42):30682-30692. PubMed ID: 24022486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
    Dinarina A; Santamaria PG; Nebreda AR
    FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
    McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
    EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speedy/Ringo C regulates S and G2 phase progression in human cells.
    Cheng A; Solomon MJ
    Cell Cycle; 2008 Oct; 7(19):3037-47. PubMed ID: 18802405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Speedy/RINGO Protein in Breast Cancer as a Future Biomarker.
    Tanriverdi O; Yildiz A
    Cancer Diagn Progn; 2024; 4(3):209-213. PubMed ID: 38707716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
    Sebastian B; Kakizuka A; Hunter T
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3521-4. PubMed ID: 8475101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the Cdk-activator Speedy/RINGO in vertebrates.
    Chauhan S; Zheng X; Tan YY; Tay BH; Lim S; Venkatesh B; Kaldis P
    Cell Mol Life Sci; 2012 Nov; 69(22):3835-50. PubMed ID: 22763696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential phosphorylation patterns between the Cyclin-A2/CDK2 complex and their monomers.
    Casado-Vela J; Martínez-Torrecuadrada JL; Casal JI
    Protein Expr Purif; 2009 Jul; 66(1):15-21. PubMed ID: 19233286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.